Literature DB >> 21183739

Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation.

Petra Kleinbongard1, Dirk Böse, Theodor Baars, Stefan Möhlenkamp, Thomas Konorza, Sandra Schöner, Miriam Elter-Schulz, Holger Eggebrecht, Hubertus Degen, Michael Haude, Bodo Levkau, Rainer Schulz, Raimund Erbel, Gerd Heusch.   

Abstract

RATIONALE: Stent implantation into atherosclerotic plaques releases, apart from particulate debris, soluble substances that contribute to impaired microvascular perfusion.
OBJECTIVE: To quantify the release of vasoconstrictors and to determine the efficacy of coronary dilators to attenuate their action. METHODS AND
RESULTS: Using a distal protection/aspiration device, coronary arterial blood was retrieved before and during stenting in 22 patients with severe saphenous vein aorto-coronary bypass stenoses. The release of catecholamines, endothelin, serotonin, thromboxane B(2), and tumor necrosis factor (TNF)α was measured. The response of rat mesenteric arteries with intact (+E) and denuded (-E) endothelium to aspirate plasma was normalized to that by KCl. Responses to selective receptor blockade, adenosine, nitroprusside, and verapamil against the aspirate-induced constriction were determined. The coronary arterial plasma withdrawn before stenting induced 21±5% and the aspirate plasma after stenting induced 95±8% of maximum KCl-induced vasoconstriction. Serotonin, thromboxane B(2), and TNFα release into aspirate plasma increased by 1.9±0.2 μmol/L, 25.6±3.1 pg/mL, and 19.7±6.1 pg/mL, respectively, during stenting. The aspirate-induced vasoconstriction was largely antagonized by selective serotonin receptor blockade, with little further antagonism by additional thromboxane receptor blockade. TNFα did not induce constriction per se but potentiated the constriction with serotonin and the thromboxane-analog U-46619 in arteries +E. The concentrations to induce half-maximal vasodilation were comparable for nitroprusside (+E, 3.3×10(-8); -E, 1.9×10(-8) mol/L) and verapamil (+E, 8.3×10(-8); -E, 7.8×10(-8) mol/L), and the vasoconstriction was eventually eliminated. The vasodilator response to adenosine was dependent on functional endothelium and weaker.
CONCLUSION: Serotonin is the main coronary vasoconstrictor after stenting, and thromboxane and TNFα somewhat potentiate the serotonin response. Nitroprusside and verapamil are more potent than adenosine to attenuate the aspirate plasma-induced vasoconstriction, and they are not dependent on functional endothelium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183739     DOI: 10.1161/CIRCRESAHA.110.235713

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  37 in total

1.  Olfactory ensheathing cells promote neurite sprouting of injured axons in vitro by direct cellular contact and secretion of soluble factors.

Authors:  R S Chung; A Woodhouse; S Fung; T C Dickson; A K West; J C Vickers; M I Chuah
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

Review 2.  Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.

Authors:  Junxi Wu; Jun Li; Nannan Zhang; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-03-23       Impact factor: 17.165

Review 3.  Cardioprotection during cardiac surgery.

Authors:  Derek J Hausenloy; Edney Boston-Griffiths; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2012-03-22       Impact factor: 10.787

4.  Link between aortic valve sclerosis and myocardial no-reflow in ST-segment elevation myocardial infarction.

Authors:  L Korkmaz; H Erkan; M T Ağaç; E Pelit; H Bektas; Z Acar; I Gurbak; F Kara; Ş Çelik
Journal:  Herz       Date:  2014-01-19       Impact factor: 1.443

Review 5.  The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.

Authors:  Derek J Hausenloy; William Chilian; Filippo Crea; Sean M Davidson; Peter Ferdinandy; David Garcia-Dorado; Niels van Royen; Rainer Schulz; Gerd Heusch
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

Review 6.  Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications.

Authors:  Jun Li; Hanrui Zhang; Cuihua Zhang
Journal:  J Mol Cell Cardiol       Date:  2011-09-05       Impact factor: 5.000

7.  Bariatric surgery reduces visceral adipose inflammation and improves endothelial function in type 2 diabetic mice.

Authors:  Hanrui Zhang; Yong Wang; Jing Zhang; Barry J Potter; James R Sowers; Cuihua Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-16       Impact factor: 8.311

Review 8.  A role for pericytes in coronary no-reflow.

Authors:  Fergus M O'Farrell; David Attwell
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 32.419

Review 9.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 10.  Coronary microvascular dysfunction in the clinical setting: from mystery to reality.

Authors:  Joerg Herrmann; Juan Carlos Kaski; Amir Lerman
Journal:  Eur Heart J       Date:  2012-08-22       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.